The ProcartaPlex 37-Plex Human Immunity Control Point Panel allows cancer research by analyzing 37 protein targets using Luminex xMAP technology. The panel consists of three modular subpanels: the 1...
The ProcartaPlex 37-Plex Human Immunity Control Point Panel allows cancer research by analyzing 37 protein targets using Luminex xMAP technology. The panel consists of three modular subpanels: Panel 1 d-immuno-oncology ProcartaPlex 14-Plex (ref. EPX14A-15803-901), Panel 2 d-immuno-oncology ProcartaPlex 14-Plex (ref. EPX140-15815-901) and panel 3 of the d-immuno-oncology control point 9-Plex ProcartaPlex (ref. EPX090-15820-901). Subpanels offer a broad initial screening to determine the target of interest and subsequent studies, by analyzing specific functional subsets of immune control point markers, which can be purchased separately. Subpanels are fully combinable with each other or with individual singlex assays corresponding to the panel targets.
ProcartaPlex preconfigured panels are widely tested for combination, interference and cross-reactivity of analytes to provide the highest level of validation and accuracy. All ProcartaPlex panels are supplied with the reagents necessary to perform the dosage. Visit our ProcartaPlex immunodosage page for more information and products available.
Target list [microbille region]: arginase-1 [51], B7-H6 [42], BTLA [52], CD134 (OX40) [55], CD137 (4-1BB) [26], CD152 (CTLA4) [33], CD27 [27], CD276 (B7-H3) [72], CD28 [15], CD47 (IAP) [74], CD48 (BLAST-1) [19], CD73 (NT5E) [30], CD80 [61], CD96 (Tactile) [35], E-cadherin [44], GITR [57], HVEM [36], ICOS ligand (B7-H2) [34], IDO [46], LAG-3 [47], MICA [18], MICB [21], nectine-2 [29], PD-1 [65], PD-L1 [66], PD-L2 [67], PVR [53], PVR [56], S100A8/A9 [76], acronym-7 [12], acronym-9 [13], TIM-3 [14], TIMD-4 [39], ULBP-1 [73], ULBP-3 [77], ULBP-4 [78], VISTA (B7-H5) [64]
ProcartaPlex immunoassays are based on the principles of a sandwich ELISA, using two highly specific antibodies binding to different epitopes of a protein to simultaneously quantify all protein targets using a Luminex instrument. ProcartaPlex multiplex assays require only 25 µl plasma or serum or 50 µl cell culture supernatant and only four hours to obtain the analyzed results.
• Reproducible and reliable results—validated as a panel according to the highest industry standard, including tests for protein target combinationability and cross-reactivity
• Plus of results per sample — simultaneously measure several protein targets in a single sample of 25–50 µL
• Well established Luminex technology—the most referenced multixing platform for protein detection and quantitative analysis
ProcartaPlex assays use Luminex xMAP (multianalyte profiling) technology for simultaneous quantitative detection and analysis of up to 80 protein targets in a single 25–50 µl sample—in plasma, serum, cell culture supernatants and other body fluids.
The microbeads of Luminex MagPlex superparamagnetic microspheres in the ProcartaPlex assay are coloured internally with precise proportions of red and infrared fluorophores to create 100 single spectrum signatures that can be identified by Luminex xMAP detection systems (Luminex 200, Flexmap 3D and MAGPIX systems). Like ELISA sandwich, the ProcartaPlex assay uses paired antibody pairs to identify the protein of interest. In a multiplexed assay, each single spectral microbead is marked with antibodies specific to a single target protein and the bound proteins are identified with biotinyl antibodies and streptavidine–R-phycoerythrin (RPE). Conjugation of protein-specific antibodies to a distinct microbead allows for analysis of several targets in a single well.
The most significant difference between ProcartaPlex and ELISA is that the capture antibody in the ProcartaPlex assay is combined with a magnetic microbead and is not absorbed into the microplate well, so that the ProcartaPlex dosing reagents float freely in the solution. For detection purposes, Luminex 200, for example, contains two lasers: one to distinguish the spectral signature from each microbead and one to quantify the amount of fluorescence of RPE. The latter is proportional to the amount of protein present in the sample. Multiplex ProcartaPlex assays can profile more target proteins using a significantly smaller sample at the same time as it is necessary to make a traditional ELISA sandwich.
ProcartaPlex multiplex panels are available in several formats for six species (human, mouse, rat, non-human primate, porcine and canine).